Prevalence of Pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening

Internal Medicine

Volumn 51, Issue 13, 2012, Pages 1677-1681

  Nakayama, Masayuki ^a,b,c   Nawa, Takeshi ^a,d   Chonan, Tatsuya ^a,e   Endo, Katsuyuki ^a,d   Morikawa, Satoshi ^a,f   Bando, Masashi ^b   Wada, Yasuhiko ^g   Shioya, Takanobu ^h   Sugiyama, Yukihiko ^b   Fukai, Shimao ^a,i  

^a Hitachi Medical Center   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Hitachi Omiya Saiseikai Hospital   (Japan)

^d Hitachi General Hospital   (Japan)

^e Nikko Memorial Hospital   (Japan)

^f Morikawa Clinic   (Japan)

^g KOCHI WOMEN S UNIVERSITY   (Japan)

^h Graduate School of Health Science   (Japan)

ⁱ Center of Chest Diseases and Severe Motor and Intellectual Disabilities   (Japan)

Author keywords

Hereditary hemorrhagic telangiectasia (HHT); Low dose CT screening; Prevalence; Pulmonary arteriovenous malformations (PAVMs)

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ABSCESS; CANCER SCREENING; CANCER STAGING; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EPISTAXIS; FEMALE; HUMAN; INTESTINE INJURY; JAPAN; LUNG ANGIOGRAPHY; LUNG CANCER; MALE; PREVALENCE; PULMONARY ARTERIOVENOUS FISTULA; RENDU OSLER WEBER DISEASE; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; PULMONARY ARTERY; PULMONARY VEINS; RETROSPECTIVE STUDIES; SEX FACTORS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 84863522255     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7305     Document Type: Article

References (17)

1. Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 158: 643-661, 1998.
2. Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. J Med Genet 48: 73-87, 2011.
3. Dakeishi M, Shioya T, Wada Y, et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 19: 140-148, 2002.
4. Nawa T, Nakagawa T, Kusano S, et al. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 122: 15-20, 2002.
5. Nawa T, Chonan T, Morikawa S, et al. Five-year experience with 1ung cancer screening using low-dose computed tomography in the Hitachi area. The Journal of the Japanese Society of CT Screening 15: 63-69, 2008 (in Japanese).
6. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiestasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91: 66-67, 2000.
7. Mountain CF. Revisions in the international system for staging lung cancer. Chest 111: 1710-1717, 1997.
8. Allen SW, Whitfield JM, Clarke DR, et al. Pulmonary arte riovenous malformation in the newborn: a familial case. Pediatr Cardiol 14: 58-61, 1993.
9. Shioya T, Eds. Practice Manual for HHT. Grant in Aid of Ministry of Health, Labor and Welfare for Rare Disease. Chugai-igakusha, Tokyo, 2011: 64-67 (in Japanese).
10. Esplin MS, Varner MW. Progression of pulmonary arteriovenous malformation during pregnancy: case report and review of the literature. Obstet Gynecol Surv 52: 248-253, 1997.
11. Gershon AS, Faughnan ME, Chon KS, et al. Transcatheter embolotherapy of maternal pulmonary arteriovenous malformations during pregnancy. Chest 119: 470-477, 2001.
12. Vase P, Holm M, Arendrup H. Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia. Acta Med Scand 218: 105-109, 1985.
13. Shovlin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 24: 203-219, 2010.
14. Cottin V, Chinet T, Lavolé A, et al. Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine 86: 1-17, 2007.
15. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245: 31-39, 1999.
16. Westermann CJ, Rosina AF, De Vries V, de Coteau PA. The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet A 116: 324-328, 2003.
17. Nawaz A, Litt HI, Stavropoulos SW, et al. Digital subtraction pulmonary arteriography versus multidetector CT in the detection of pulmonary arteriovenous malformations. J Vasc Interv Radiol 19: 1582-1588, 2008.